Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
LBR
LB Pharmaceuticals Inc
LBRX
Return on equity
Return on equity at other companies
Bristol-Myers Squibb
BMY
46.7%
+17.8pp
Alkermes
ALKS
3.9%
-20.1pp
Alto Neuroscience
ANRO
-38.9%
+0.9pp
Acadia Pharmaceuticals
ACAD
35.7%
+2.6pp
Xenon Pharmaceuticals
XENE
-43.6%
+8.2pp
RFL
Rafael Holdings, Inc.
RFL
-26.6%
-0.8pp
Other financials
Income statement
See full
Net income
-$19.1M
-259%
EPS (diluted)
-$0.67
+95.5%
Balance sheet
See full
Cash & equivalents
$320.7M
—
Total debt
$3.5M
—
Total equity
$378.7M
+481%
Total assets
$393.5M
—
Cash flow
See full
Operating cash flow
-$23.3M
-187%
CapEx
$32.0K
+52.4%
Free cash flow
-$23.3M
-186%
Valuation
See full
Market cap
$1.38B
+308%
Enterprise value
$1.06B
—
Returns & leverage
See full
Debt / equity
0×
—
Current ratio
35.7×
—
Watchlist
Screener
Filings
Earnings
Charts